But also
Rated 5 out of 5 Deborah C
Additional approaches include liposomal encapsulation, which mimics cell membrane structure to enhance cellular uptake, and emulsion-based systems that improve dispersion in water-based formulations
In this weeks issue of The Savvy Diabetic: FDA Approves Kristy Biosimilar to Novolog Dexcom Responds to Sensor Failures & More Ozempic Teeth GLP-1 Side Effect Innovations in Preventing/Treating Hypos Type 1 Diabetes Companion Cards by Alex Durussel-Baker Hypothyroidism Linked to Gut Microbiome New Form of T1D Identified in Africa NIDDK STUDY: CGM with Data Sharing in Older Adult T1Ds Male Virility Affected By Minimal Rises In BGs Doctors Using AI Perceived Less Favorably Psychologists ID 3rd Path to Good Life Full of Curiosity & Challenge Kirsty, an Interchangeable Biosimilar to Novolog, Gets FDA Approval by Jaymin Kang, PharmD for EndocrinologyAdvisor.com, 18 July 2025
This was a small pilot study, so larger trials are needed before MST can be offered more broadly
I cant help but be a little vexed by yet another catchy, scapegoating term for something that may not, in many cases, be directly caused by GLP-1 use